ArticleJID innovations : skin science from molecules to population health2026
Artificial intelligence-based quantification of epidermal proliferation and apoptosis in human skin.
Article in JID innovations : skin science from molecules to population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although artificial intelligence is rapidly advancing, its application in translational dermatological research remains limited. In this study, we established an artificial intelligence-based image analysis workflow for the quantification of proliferation and apoptosis within the human epidermis using 3,3'-diaminobenzidine-based immunohistochemical staining. Human skin cultured in a 3-dimensional in vivo model was processed using paraffin embedding and immunohistochemical staining for Ki-67 and cleaved Caspase-3. We implemented an artificial intelligence-based 2-model workflow: a custom-trained convolutional neural network-based model for cell detection and a semantic-segmentation model that specifically segregates the epidermis. By combining both models, we restricted cell annotation and classification to the epidermis-our structure of interest-enabling epidermis-constrained quantification on whole-slide images. Validation against manual counts showed high agreement for both markers (Ki-67 mean accuracy = 95.43%; cleaved Caspase-3 = 97.0%) across staining batches and time points. To test the experimental applicability of our workflow, we treated human skin cultured on the chorioallantoic membrane with hydroxytyrosol. The artificial intelligence-based workflow minimized subjective bias and provided a coherent readout, showing reduced proliferation without inducing apoptotic responses in hydroxytyrosol-treated samples. Overall, the workflow achieved strong performance with modest training effort and annotation, offering a scalable approach that supports translational dermatological research and holds potential for dermatopathological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.